XI’AN, China, July 22 /PRNewswire-Asia-FirstCall/ —
Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board:
HFGB), specializing in developing and producing botanical extracts
and other raw materials for pharmaceuticals and food additives,
today announced the receipt of its European order for approximately
80 metric tons of Diosmin from Galenicum Health S.L., a Spanish
pharmaceutical company. This order is valued at approximately $3.8 million with shipments between August 2010 and July
2011.
Jing’an Wang, the Company’s CEO, stated, “I am excited to share
news of this purchase order with our investors. HFGB is the only
pharmaceutical company in China
which has obtained GMP certification and applied for the
Certification of Suitability to Monograph of European Pharmacopoeia
(“COS”) from the European Directorate for the quality of medicine.
We currently have customers throughout the world, including France, Japan, South
Korea, Australia, Southeast Asia, Russia, India, Germany and the U.S. Once the Company
receives COS approval, we believe that the Company will continue to
expand its global market share.”
About Diosmin
Diosmin is a flavonoid that can be isolated from various plant
sources or derived from the flavonoid hesperidin. Diosmin is used
as a pharmaceutical material as a supplement to treat chronic
venous insufficiency, hemorrhoids, lymphedema, and varicose
vein
‘/>”/>
